{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T11:28:34Z","timestamp":1740137314630,"version":"3.37.3"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,1,4]],"date-time":"2019-01-04T00:00:00Z","timestamp":1546560000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1007\/s10238-018-00542-7","type":"journal-article","created":{"date-parts":[[2019,1,4]],"date-time":"2019-01-04T00:30:54Z","timestamp":1546561854000},"page":"245-254","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Effect of antithyroid drugs on the occurrence of antibodies against type 2 deiodinase (DIO2), which are involved in hyperthyroid Graves\u2019 disease influencing the therapeutic efficacy"],"prefix":"10.1007","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8375-0357","authenticated-orcid":false,"given":"Ildik\u00f3","family":"Moln\u00e1r","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f3zsef A.","family":"Szentmikl\u00f3si","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rudolf","family":"Gesztelyi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c9va","family":"Somogyin\u00e9-V\u00e1ri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,1,4]]},"reference":[{"key":"542_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2017.00521","volume":"8","author":"E Fr\u00f6hlich","year":"2017","unstructured":"Fr\u00f6hlich E, Wahl R. Thyroid autoimmunity: role of anti-thyroid antibodies in thyroid and extra-thyroidal disease. Front Immunol. 2017;8:1\u201315.","journal-title":"Front Immunol"},{"key":"542_CR2","first-page":"1735","volume":"55","author":"Y Wang","year":"2014","unstructured":"Wang Y, Smith TJ. Current concepts in the molecular pathogenesis of thyroid-associated ophthalmopathy. IOVS. 2014;55:1735\u201348.","journal-title":"IOVS"},{"key":"542_CR3","first-page":"6677","volume":"8","author":"FA Ikhan","year":"2015","unstructured":"Ikhan FA, Al-Jameil N, Khan MF, Al-Rashid M, Tabassum F. Thyroid dysfunction: an autoimmune aspect. Int J Clin Exp Med. 2015;8:6677\u201381.","journal-title":"Int J Clin Exp Med"},{"key":"542_CR4","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1530\/EJE-10-0736","volume":"164","author":"M Ito","year":"2011","unstructured":"Ito M, Toyoda N, Nomura E, et al. Type 1 and type 2 iodothyronine deiodinases in the thyroid gland of patients with 3,5,3\u2032-triiodothyronine-predominant Graves\u2019 disease. Eur J Endocrinol. 2011;164:95\u2013100.","journal-title":"Eur J Endocrinol"},{"key":"542_CR5","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1210\/jc.2007-0178","volume":"92","author":"P Laurberg","year":"2007","unstructured":"Laurberg P, Vestergaard H, Nielsen S, et al. Sources of circulating 3,5,3\u2032-triiodothyronine in hyperthyroidism estimated after blocking of type 1 and type 2 iodothyronine deiodinases. J Clin Endocrinol Metab. 2007;92:2149\u201356.","journal-title":"J Clin Endocrinol Metab"},{"key":"542_CR6","doi-asserted-by":"publisher","first-page":"3308","DOI":"10.1210\/endo.137.8.8754756","volume":"137","author":"D Salvatore","year":"1996","unstructured":"Salvatore D, Bartha T, Harney JW, Larsen PR. Molecular biological and biochemical characterization of the human type 2 selenodeiodinase. Endocrinology. 1996;137:3308\u201315.","journal-title":"Endocrinology"},{"key":"542_CR7","doi-asserted-by":"publisher","DOI":"10.1155\/BCA\/2006\/23214","author":"G Roy","year":"2006","unstructured":"Roy G, Mugesh G. Bioinorganic chemistry in thyroid gland: effect of antithyroid drugs on peroxidase-catalyzed oxidation and iodination reactions. Bioinorg Chem Appl. 2006. \n                    https:\/\/doi.org\/10.1155\/BCA\/2006\/23214\n                    \n                  .","journal-title":"Bioinorg Chem Appl"},{"key":"542_CR8","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1507\/endocrj.K09E-230","volume":"57","author":"R Ishi","year":"2010","unstructured":"Ishi R, Imaizumi M, Ide A, et al. A long-term follow-up of serum myeloperoxidase antineutrophil cytoplasmic antibodies (MPO-ANCA) in patients with Graves\u2019 disease treated with propylthiouracil. Endocr J. 2010;57:73\u20139.","journal-title":"Endocr J"},{"key":"542_CR9","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1210\/jcem-44-1-203","volume":"44","author":"SC Werner","year":"1977","unstructured":"Werner SC. Modification of classification of eye changes of Graves\u2019 disease: recommendations of the Ad Hoc Committee of American Thyroid Association. J Clin Endocrinol Metab. 1977;44:203\u20134.","journal-title":"J Clin Endocrinol Metab"},{"key":"542_CR10","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1046\/j.1365-2265.1997.2331047.x","volume":"47","author":"MP Mourits","year":"1997","unstructured":"Mourits MP, Prummel MF, Wiersinga WM, Koornneef L. Clinical activity score as a guide in the management of patients with Graves\u2019 ophthalmopathy. Clin Endocrinol (Oxf). 1997;47:9\u201314.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"542_CR11","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1007\/s10875-006-9063-x","volume":"27","author":"I Moln\u00e1r","year":"2007","unstructured":"Moln\u00e1r I, Szombathy Z, Kov\u00e1cs I, Szentmikl\u00f3si AJ. Immunohistochemical studies using immunized guinea pig sera with features of anti-human thyroid, eye and skeletal antibody and Graves\u2019 sera. J Clin Immunol. 2007;27:172\u201380.","journal-title":"J Clin Immunol"},{"key":"542_CR12","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1111\/j.1749-6632.2000.tb05371.x","volume":"917","author":"GP Chrousos","year":"2000","unstructured":"Chrousos GP. The stress response and immune function: clinical implications. The 1999 Novera H. Spector lecture. Ann NY Acad Sci. 2000;917:38\u201367.","journal-title":"Ann NY Acad Sci"},{"key":"542_CR13","doi-asserted-by":"publisher","first-page":"2705","DOI":"10.1021\/ar4001229","volume":"46","author":"D Manna","year":"2013","unstructured":"Manna D, Roy G, Mugesh G. Antithyroid drugs and their analogues: synthesis, structure, and mechanism of action. Acc Chem Res. 2013;46:2705\u201315.","journal-title":"Acc Chem Res"},{"key":"542_CR14","doi-asserted-by":"publisher","first-page":"15207","DOI":"10.1021\/ja054497u","volume":"127","author":"G Roy","year":"2005","unstructured":"Roy G, Mugesh G. Anti-thyroid drugs and thyroid hormone synthesis: effect of methimazole derivatives on peroxidase-catalyzed reactions. J Am Chem Soc. 2005;127:15207\u201317.","journal-title":"J Am Chem Soc"},{"key":"542_CR15","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/0006-2952(94)00505-G","volume":"49","author":"A Taurog","year":"1995","unstructured":"Taurog A, Dorris ML, Hu WX, Guziec FS. The selenium analog of 6-propylthiouracil. Measurement of its inhibitory effect on type I iodothyronine deiodinase and of its antithyroid activity. Biochem Pharmacol. 1995;49:701\u20139.","journal-title":"Biochem Pharmacol"},{"key":"542_CR16","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1210\/jcem-43-1-152","volume":"43","author":"A Nagasaka","year":"1976","unstructured":"Nagasaka A, Hidaka H. Effect of antithyroid agents 6-propyl-2-thiouracil and 1-methyl-2-mercaptoimidazole on human thyroid iodine peroxidase. J Clin Endocrinol Metab. 1976;43:152\u20138.","journal-title":"J Clin Endocrinol Metab"},{"key":"542_CR17","doi-asserted-by":"publisher","first-page":"28037","DOI":"10.1074\/jbc.M101942200","volume":"276","author":"G Lian","year":"2001","unstructured":"Lian G, Ding L, Chen M, Liu Z, Zhao D, Ni J. Preparation and properties of a selenium-containing catalytic antibody as type 1 deiodinase mimic. J Biol Chem. 2001;276:28037\u201341.","journal-title":"J Biol Chem"},{"key":"542_CR18","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1046\/j.1432-1033.2003.03576.x","volume":"270","author":"ACF Ferreira","year":"2003","unstructured":"Ferreira ACF, Cardoso LC, Rosenthal D, Carvalho DP. Thyroid Ca2+\/NADPH-dependent H2O2 generation is partially inhibited by propylthiouracil and methimazole. Eur J Biochem. 2003;270:2363\u20138.","journal-title":"Eur J Biochem"},{"key":"542_CR19","first-page":"3293","volume":"84","author":"Y Hosoi","year":"1999","unstructured":"Hosoi Y, Murakami M, Mizuma H, Ogiwara T, Imamura M, Masatomo M. Expression and regulation of type II iodothyronine deiodinase in cultured human skeletal muscle cells. J Clin Endocrinol Metab. 1999;84:3293\u2013300.","journal-title":"J Clin Endocrinol Metab"},{"key":"542_CR20","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1507\/endocrj.50.45","volume":"50","author":"T Kashiwai","year":"2003","unstructured":"Kashiwai T, Hidaka Y, Takano T, et al. Practical treatment with minimum maintenance dose of antithyroid drugs for prediction of remission in Graves\u2019 disease. Endocr J. 2003;50:45\u20139.","journal-title":"Endocr J"},{"key":"542_CR21","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1055\/s-0033-1363193","volume":"122","author":"M Lantz","year":"2014","unstructured":"Lantz M, Planck T, Asman P, Hallengren B. Increased TRAb and\/or low anti-TPO titers at diagnosis of Graves\u2019 disease are associated with an increased risk of developing ophthalmopathy after onset. Exp Clin Endocrinol Diabetes. 2014;122:113\u20137.","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"542_CR22","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0165-2478(01)00301-7","volume":"80","author":"I Moln\u00e1r","year":"2002","unstructured":"Moln\u00e1r I, Balazs C, Szegedi G, Sipka S. Inhibition of type 2,5\u2032-deiodinase by tumor necrosis factor alpha, interleukin-6 and interferon gamma in human thyroid tissue. Immunol Lett. 2002;80:3\u20137.","journal-title":"Immunol Lett"},{"key":"542_CR23","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3109\/08916939708996275","volume":"25","author":"I Moln\u00e1r","year":"1997","unstructured":"Moln\u00e1r I, Bal\u00e1zs C. High circulating IL-6 in Graves\u2019 ophthalmopathy. Autoimmunity. 1997;25:91\u20136.","journal-title":"Autoimmunity"},{"key":"542_CR24","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1507\/endocrj.52.691","volume":"52","author":"R Nakahar","year":"2005","unstructured":"Nakahar R, Tsunekawa K, Yabe S, et al. Association of antipituitary antibody and type 2 iodothyronine deiodinase antibody in patients with autoimmune thyroid disease. Endocr J. 2005;52:691\u20139.","journal-title":"Endocr J"},{"key":"542_CR25","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1136\/jmg.2004.019190","volume":"41","author":"TW Guo","year":"2004","unstructured":"Guo TW, Zhang FC, Yang MS, et al. Positive association of DIO2 (deiodinase type 2) gene with mental retardation in the iodine-deficient areas of China. J Med Genet. 2004;41:585\u201390.","journal-title":"J Med Genet"},{"key":"542_CR26","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1210\/jc.2006-1958","volume":"92","author":"N Grarup","year":"2007","unstructured":"Grarup N, Andersen MK, Andreasen CH, et al. Studies of the common DIO2 Thr92Ala polymorphism and metabolic phenotypes in 7342 danish white subjects. J Clin Endocrinol Metab. 2007;92:363\u20136.","journal-title":"J Clin Endocrinol Metab"},{"key":"542_CR27","doi-asserted-by":"publisher","first-page":"E1527","DOI":"10.1210\/jc.2011-0235","volume":"96","author":"HC Hoftijzer","year":"2011","unstructured":"Hoftijzer HC, Heemstra KA, Visser TJ, et al. The type deiodinase ORFa-Gly3Asp polymorphism (rs12885300) influences the set point of the hypothalamus\u2013pituitary\u2013thyroid axis in patients treated for differentiated thyroid carcinoma. J Clin Endocrinol Metab. 2011;96:E1527\u201333.","journal-title":"J Clin Endocrinol Metab"},{"key":"542_CR28","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1210\/edrv.23.1.0455","volume":"23","author":"AC Bianco","year":"2002","unstructured":"Bianco AC, Salvatore D, Gereben B, Berry MJ, Larsen PR. Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases. Endocr Rev. 2002;23:38\u201389.","journal-title":"Endocr Rev"},{"key":"542_CR29","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1172\/JCI107744","volume":"54","author":"J Abuid","year":"1974","unstructured":"Abuid J, Larsen PR. Triiodothyronine and thyroxine in hyperthyroidism. Comparison of the acute changes during therapy with antithyroid agents. J Clin Investig. 1974;54:201\u20138.","journal-title":"J Clin Investig"},{"key":"542_CR30","doi-asserted-by":"publisher","first-page":"R37","DOI":"10.1530\/JME-15-0156","volume":"55","author":"U Schweizer","year":"2015","unstructured":"Schweizer U, Steegborn C. New insights into the structure and mechanism of iodothyronine deiodinases. J Mol Endocrinol. 2015;55:R37\u201352.","journal-title":"J Mol Endocrinol"},{"key":"542_CR31","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1159\/000355288","volume":"2","author":"E Rijntjes","year":"2013","unstructured":"Rijntjes E, Scholz PM, Mugesh G, K\u00f6hrle J. Se- and S-based thiouracil and methimazole analogues exert different inhibitory mechanisms on type 1 and type 2 deiodinases. Eur Thyroid J. 2013;2:252\u20138.","journal-title":"Eur Thyroid J"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-018-00542-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10238-018-00542-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-018-00542-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,3]],"date-time":"2020-01-03T19:26:25Z","timestamp":1578079585000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10238-018-00542-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,4]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["542"],"URL":"https:\/\/doi.org\/10.1007\/s10238-018-00542-7","relation":{},"ISSN":["1591-8890","1591-9528"],"issn-type":[{"type":"print","value":"1591-8890"},{"type":"electronic","value":"1591-9528"}],"subject":[],"published":{"date-parts":[[2019,1,4]]},"assertion":[{"value":"30 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standard of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"For this type of study, formal consent was not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}